225 related articles for article (PubMed ID: 16266820)
1. Screening for distant metastases in patients with head and neck cancer: is there a role for (18)FDG-PET?
Brouwer J; Senft A; de Bree R; Comans EF; Golding RP; Castelijns JA; Hoekstra OS; Leemans CR
Oral Oncol; 2006 Mar; 42(3):275-80. PubMed ID: 16266820
[TBL] [Abstract][Full Text] [Related]
2. FDG-PET and detection of distant metastases and simultaneous tumors in head and neck squamous cell carcinoma: a comparison with chest radiography and chest CT.
Krabbe CA; Pruim J; van der Laan BF; Rödiger LA; Roodenburg JL
Oral Oncol; 2009 Mar; 45(3):234-40. PubMed ID: 18715818
[TBL] [Abstract][Full Text] [Related]
3. Chest CT and whole-body 18F-FDG PET are cost-effective in screening for distant metastases in head and neck cancer patients.
Uyl-de Groot CA; Senft A; de Bree R; Leemans CR; Hoekstra OS
J Nucl Med; 2010 Feb; 51(2):176-82. PubMed ID: 20124045
[TBL] [Abstract][Full Text] [Related]
4. Screening for distant metastases in head and neck cancer patients by chest CT or whole body FDG-PET: a prospective multicenter trial.
Senft A; de Bree R; Hoekstra OS; Kuik DJ; Golding RP; Oyen WJ; Pruim J; van den Hoogen FJ; Roodenburg JL; Leemans CR
Radiother Oncol; 2008 May; 87(2):221-9. PubMed ID: 18410977
[TBL] [Abstract][Full Text] [Related]
5. Chest radiography or chest CT plus head and neck CT versus
Kim Y; Roh JL; Kim JS; Lee JH; Choi SH; Nam SY; Kim SY
Oral Oncol; 2019 Jan; 88():109-114. PubMed ID: 30616780
[TBL] [Abstract][Full Text] [Related]
6. The value of (18)F-FDG PET/CT for the detection of distant metastases in high-risk patients with head and neck squamous cell carcinoma.
Haerle SK; Schmid DT; Ahmad N; Hany TF; Stoeckli SJ
Oral Oncol; 2011 Jul; 47(7):653-9. PubMed ID: 21658990
[TBL] [Abstract][Full Text] [Related]
7. Screening for distant metastases in head and neck cancer patients using FDG-PET and chest CT: validation of an algorithm.
Senft A; Hoekstra OS; Witte BI; Leemans CR; de Bree R
Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2643-50. PubMed ID: 26350882
[TBL] [Abstract][Full Text] [Related]
8. The impact of FDG-PET/CT on the management of head and neck tumours: the radiotherapist's perspective.
Dietl B; Marienhagen J; Kühnel T; Schreyer A; Kölbl O
Oral Oncol; 2008 May; 44(5):504-8. PubMed ID: 17826307
[TBL] [Abstract][Full Text] [Related]
9. The value of 18F-FDG PET in the detection of stage M0 carcinoma of the nasopharynx.
Yen TC; Chang JT; Ng SH; Chang YC; Chan SC; Lin KJ; Lin WJ; Fu YK; Lin CY
J Nucl Med; 2005 Mar; 46(3):405-10. PubMed ID: 15750151
[TBL] [Abstract][Full Text] [Related]
10. 18F-FDG PET/CT for detecting distant metastases in patients with recurrent head and neck squamous cell carcinoma.
Yi JS; Kim JS; Lee JH; Choi SH; Nam SY; Kim SY; Roh JL
J Surg Oncol; 2012 Nov; 106(6):708-12. PubMed ID: 22674652
[TBL] [Abstract][Full Text] [Related]
11. Staging of head and neck squamous cell cancer with extended-field FDG-PET.
Schwartz DL; Rajendran J; Yueh B; Coltrera M; Anzai Y; Krohn K; Eary J
Arch Otolaryngol Head Neck Surg; 2003 Nov; 129(11):1173-8. PubMed ID: 14623746
[TBL] [Abstract][Full Text] [Related]
12. Whole-body (18)F-fluorodeoxyglucose positron emission tomography in patients with head and neck cancer.
Kitagawa Y; Nishizawa S; Sano K; Sadato N; Maruta Y; Ogasawara T; Nakamura M; Yonekura Y
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Feb; 93(2):202-7. PubMed ID: 11862212
[TBL] [Abstract][Full Text] [Related]
13. Preoperative evaluation of patients with primary head and neck cancer using dual-head 18fluorodeoxyglucose positron emission tomography.
Stokkel MP; ten Broek FW; Hordijk GJ; Koole R; van Rijk PP
Ann Surg; 2000 Feb; 231(2):229-34. PubMed ID: 10674615
[TBL] [Abstract][Full Text] [Related]
14. Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities.
Regelink G; Brouwer J; de Bree R; Pruim J; van der Laan BF; Vaalburg W; Hoekstra OS; Comans EF; Vissink A; Leemans CR; Roodenburg JL
Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1024-30. PubMed ID: 12173016
[TBL] [Abstract][Full Text] [Related]
15. Clinical values for abnormal ¹⁸F-FDG uptake in the head and neck region of patients with head and neck squamous cell carcinoma.
Lee HS; Kim JS; Roh JL; Choi SH; Nam SY; Kim SY
Eur J Radiol; 2014 Aug; 83(8):1455-60. PubMed ID: 24929443
[TBL] [Abstract][Full Text] [Related]
16. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors.
Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2009 Mar; 45(3):218-24. PubMed ID: 18804404
[TBL] [Abstract][Full Text] [Related]
17. Potential for truncating the scan length of restaging FDG-PET/CT after chemoradiotherapy in head and neck squamous cell carcinoma.
Huang YT; Ravi Kumar AS
Nucl Med Commun; 2012 May; 33(5):503-8. PubMed ID: 22262244
[TBL] [Abstract][Full Text] [Related]
18. Detection of occult bone metastases from head and neck squamous cell carcinoma: impact of positron emission tomography computed tomography with fluorodeoxyglucose F 18.
Basu D; Siegel BA; McDonald DJ; Nussenbaum B
Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):801-5. PubMed ID: 17709620
[TBL] [Abstract][Full Text] [Related]
19. Identification of distant metastases with positron-emission tomography-computed tomography in patients with previously untreated head and neck cancer.
Gourin CG; Watts TL; Williams HT; Patel VS; Bilodeau PA; Coleman TA
Laryngoscope; 2008 Apr; 118(4):671-5. PubMed ID: 18197136
[TBL] [Abstract][Full Text] [Related]
20. The adverse impact of surveillance intervals on the sensitivity of FDG-PET/CT for the detection of distant metastases in head and neck cancer patients.
Senft A; Yildirim G; Hoekstra OS; Castelijns JA; René Leemans C; de Bree R
Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):1113-1120. PubMed ID: 27804082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
